Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.17p
   
  • Change Today:
    -0.080p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 909,078
  • Market Cap: £10.84m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £32,300
Lisa Baderoon 583,963 £12,672
Tim Franklin 525,000 £11,392

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £1,409,027
Luca & Associates AG 22,000,000 £477,400
Invesco Ltd 17,872,341 £387,830
Aviva Investors Global 11,285,180 £244,888
Alora Pharmaceuticals LLC 10,909,091 £236,727
M&G Investments 7,600,000 £164,920
Prudential plc 7,600,000 £164,920
Capital Income Builder 4,870,367 £105,687
Dr R Zimmer 4,551,553 £98,769
Odey Asset Management 3,433,319 £74,503
Rhone Trustees (Switzerland) SA 3,386,000 £73,476
Pictet Overseas Trust Corporation Limited 3,287,500 £71,339

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.17p
Change Today -0.080p
% Change -3.56 %
52 Week High 5.90
52 Week Low 1.09
Volume 909,078
Shares Issued 499.72m
Market Cap £10.84m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.92% below the market average28.92% below the market average28.92% below the market average28.92% below the market average28.92% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Price Trend
45.58% above the market average45.58% above the market average45.58% above the market average45.58% above the market average45.58% above the market average
69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 04-Jul-2025

Time Volume / Share Price
16:15 25,000 @ 2.14p
16:13 35,000 @ 2.14p
16:09 15,000 @ 2.12p
16:08 15,000 @ 2.12p
15:48 108 @ 2.12p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page